Nyxoah (NYXH) EPS (Weighted Average and Diluted) (2021 - 2026)

Nyxoah (NYXH) recorded quarterly EPS (Weighted Average and Diluted) of $44.0 million in Q1 2026, down 99.56% quarter-over-quarter from $9.9 billion in Q4 2025, and up 17.66% on a YoY basis from $37.4 million in Q1 2025.

Nyxoah (NYXH) EPS (Weighted Average and Diluted) (2021 - 2026) Analysis & Trends

Nyxoah's EPS (Weighted Average and Diluted) history runs 6 years deep, the most recent figure standing at $44.0 million for Q1 2026.

  • In Q1 2026, EPS (Weighted Average and Diluted) rose 17.66% year-over-year to $44.0 million; the TTM figure through Mar 2026 stood at $44.0 million (up 17.66% YoY), while the FY2025 annual figure was -$2.75, down 42.35% from the prior year.
  • EPS (Weighted Average and Diluted) was $44.0 million for Q1 2026 at Nyxoah, down from $9.9 billion in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $26.0 billion in Q1 2023 to a low of -$9.5 million in Q4 2024.
  • Historically, EPS (Weighted Average and Diluted) has averaged $2.1 billion across 5 years, with a median of $14.2 million in 2023.
  • The sharpest annual moves came in 2022 and 2023: EPS (Weighted Average and Diluted) plunged 194.0% in 2022, then jumped 128177.05% in 2023.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $11.0 million in 2022, then sank by 164.05% to -$7.1 million in 2023, then sank by 34.46% to -$9.5 million in 2024, then jumped by 105020.5% to $9.9 billion in 2025, then tumbled by 99.56% to $44.0 million in 2026.
  • The last three EPS (Weighted Average and Diluted) figures came in at $44.0 million (Q1 2026), $9.9 billion (Q4 2025), and $13.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Weighted Avg. Diluted) (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn 2.28
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn -1.11
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn 0.16
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn 2.74
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn 1.92
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn 0.07
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn -0.40
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn 1.57
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn -0.03
10 Nyxoah 0.69 0.69 4.26 Mn 44.05 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 44.05 Mn
Dec 31, 2025 9.95 Bn
Sep 30, 2025 13.28 Mn
Jun 30, 2025 17.73 Mn
Mar 31, 2025 37.43 Mn
Dec 31, 2024 -9.48 Mn
Sep 30, 2024 12.83 Mn
Jun 30, 2024 15.67 Mn
Mar 31, 2024 28.69 Mn
Dec 31, 2023 -7.05 Mn
Sep 30, 2023 -6.54 Mn
Jun 30, 2023 14.16 Mn
Mar 31, 2023 25.95 Bn
Dec 31, 2022 11.01 Mn
Sep 30, 2022 -8.98 Mn
Jun 30, 2022 11,041.94
Mar 31, 2022 26.17 Mn
Dec 31, 2021 5.45 Mn
Sep 30, 2021 9.55 Mn
Jun 30, 2021 12,173.68